ImYoo

Longitudinal, at-home sampling can uncover signals that could otherwise be missed in traditional studies. This was a perfect use case of our approach to study design - give participants the tools to capture their immune system at times of critical events, and let the data speak. Thank you Remission Biome for the opportunity to collaborate with you on this study, and Complete Genomics for providing the sequencing!

Check out our learnings on the power of online patient networking for growing our single-cell at home studies! https://lnkd.in/gKcja42g

ImYoo is excited to announce a collaboration with Wilson Liao lab at University of California, San Francisco to study how environmental exposure impacts flares in psoriasis and atopic dermatitis. Over a year, patients will collect samples at home when experiencing skin disease fluctuations. ImYoo will leverage powerful single-cell measurements to search for molecular signals associated with environmental factors and immune flare-ups. Environmental exposure plays a large role across numerous conditions, and we're excited to deploy ImYoo's platform to better understand its impact on disease!

We're working with Tess McEnulty Falor, PhD& Tamara Romanuk from RemissionBiome to better understand immune response at cellular resolution in interventions for ME/CFS. Thank you Complete Genomics Inc. for your support! Excited to see what this data uncovers for this understudied and complex disease!

In June, our team of 6 launched its first decentralized, longitudinal research study. How's it going? 🌎 We're in 19 US states 🙋♀️ We're 12 participants away from hitting our recruitment goal 🙌🏾 More than a third of our participants are racial minorities Read more about it in our blog post: https://lnkd.in/gmij_g8m Know someone in a Crohn's disease or ulcerative colitis flare-up? There's still room in our study! Share the blog with them, too, or have them visit imyoo.health/ibd. ... #inflammatoryboweldisease #ibdflareup #crohnsdisease #ulcerativecolitis